Roderick de Greef Concludes 20 Year Association with BioLife BOTHELL, Wash., Sept. 15, 2021 /PRNewswire/ — BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that Roderick de Greef, Chief Financial Officer, plans to retire on December 31,... Read more
BOTHELL, Wash., May 3, 2021 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed the previously announced acquisition of Stirling Ultracold (“Stirling”), a privately held manufacturer of ultra-low... Read more
BOTHELL, Wash., April 15, 2021 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an initial shipment to a leading cell therapy... Read more
BOTHELL, Wash., April 6, 2021 /PRNewswire/ —BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has appointed Amy DuRoss, chief executive officer of Vineti, and Rachel Ellingson, senior vice president and chief strategy officer at Zimmer Biomet... Read more
BOTHELL, Wash., March 22, 2021 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced the signing of a definitive merger agreement to acquire Global Cooling, Inc., operating as Stirling Ultracold (“Stirling”), a privately held manufacturer of... Read more
Reduced in-transit shipping damage, Extended dynamic thermal performance and Predictive Analytics in Next Generation Dry Vapor Liquid Nitrogen Shippers BOTHELL, Wash., July 30, 2019 /PRNewswire/ —BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that SAVSU Technologies, a leading developer of advanced... Read more
evo® Cold Chain Management System and LifeGuard Same Day Service Reduce Risks for High-Value, Temperature-Sensitive Biologic Drugs BOTHELL, Wash., July 23, 2019 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that SAVSU Technologies, a leading developer of advanced cold chain... Read more
Acquisition further strengthens portfolio of best in class, proprietary enabling solutions for cell and gene therapy companiesSAVSU experiencing accelerated commercial momentum for its cloud-based evo® Cold Chain Management System BOTHELL, Wash., July 8, 2019 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary biopreservation media and automated cell thawing media devices for cell... Read more
Gains products that automate the thawing process for high-value biologic therapies Provides access to addressable market projected to exceed $150 million by 2024 BOTHELL, Wash., April 2, 2019 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife”) today announced that it has closed the previously announced transaction for the acquisition of Astero Bio Corporation (“Astero”), an innovator in the design, development and... Read more
BOTHELL, Wash., March 14, 2019 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife”) today announced that it has entered into an agreement to acquire Astero Bio Corporation (“Astero”), a privately-held innovator in the design, development and commercialization of novel automated thawing devices, for an upfront cash payment of $8.0 million. This transaction is expected to further strengthen BioLife’s position as a leading... Read more